UMOD and chronic kidney disease: The presence in urine of collagen fragments, α1-microglobulin, β2-microglobulin (β2MG), α1 antitrypsin (A1AT), and uromodulin, among other peptides, has shown that they could be promising biomarkers to detect individuals with T2DM who are at high risk of developing CKD (61).